Neeraj Agarwal, MD

Articles by Neeraj Agarwal, MD

Dr. Agarwal on Second-Line Therapy Selection in Metastatic RCC

January 4th 2019

Neeraj Agarwal, MD, associate professor, Division of Oncology, Department of Medicine, University of Utah School of Medicine, Huntsman Cancer Institute, discusses second-line therapy selection in metastatic renal cell carcinoma.

Second-Line Therapy Options in Metastatic Renal Cell Carcinoma

ByNeeraj Agarwal, MD

August 1st 2017

This video reviews the various treatment options for metastatic renal cell carcinoma in the second-line setting, including considerations for different toxicity profiles.

Latest Updated Articles

Second-Line Therapy Options in Metastatic Renal Cell Carcinoma
Published: August 1st 2017 | Updated:
Dr. Agarwal on Second-Line Therapy Selection in Metastatic RCC
Published: January 4th 2019 | Updated: